Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a potentially fatal disease with high mortality. Our aim was to summarize the current evidence for use of neuromuscular blocking agents (NMBA) in the early phase of ARDS. METHODS: Systematic review and meta-analysis of publications between 19...

Descripción completa

Detalles Bibliográficos
Autores principales: Neto, Ary Serpa, Pereira, Victor Galvão Moura, Espósito, Daniel Crepaldi, Damasceno, Maria Cecília Toledo, Schultz, Marcus J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475105/
https://www.ncbi.nlm.nih.gov/pubmed/22835162
http://dx.doi.org/10.1186/2110-5820-2-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475105/
https://www.ncbi.nlm.nih.gov/pubmed/22835162
http://dx.doi.org/10.1186/2110-5820-2-33

Ejemplares similares